Peripheral artery disease: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• PCSK9 1
• IL-17 1

EU-13 is a filter, not a ranking: it only narrows the list.

No research groups match this view yet.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Suspended

  Clinical Performance of the VESTO® Vascular Stent for Treatment of Iliac Peripheral Obstructive Arterial Disease

  NCT06573437· Braile Biomedica Ind. Com. e Repr. Ltda.· Updated 2 Nov 2026

  “Low recruitment potential, limiting the feasibility of achieving the planned sample size.”Registry text, quoted unchanged. Source

• Withdrawn

  Shortwave Diathermy In-home Treatment for Indianapolis VA-only Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy

  NCT07336381· Indiana University· Updated 29 Oct 2026

  “Funding issues”Registry text, quoted unchanged. Source

• Terminated

  AcoArt Litos PCB Below-the-knee Global Trial

  NCT06330493· Acotec Scientific Co., Ltd· Updated 26 Aug 2026

  “Terminated based on a corporate strategic decision regarding portfolio prioritization. The termination is not due to any identified safety signals, device performance concern, or change in the benefit-risk assessment of the AcoArt Litos PCB Catheter.”Registry text, quoted unchanged. Source

• Withdrawn

  Leg Exercise Assistive Paddling (LEAP) Therapy for Peripheral Artery Disease

  NCT06389149· University of Nebraska· Updated 21 Aug 2026

  “PI has left institute and study could not be continued.”Registry text, quoted unchanged. Source

• Terminated

  The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions

  NCT04007055· Marissa Jarosinski· Updated 6 Jul 2026

  “Poor recruitment”Registry text, quoted unchanged. Source

• Withdrawn

  Heat Therapy for Peripheral Arterial Disease (HEATPAD)

  NCT06186505· Norfolk and Norwich University Hospitals NHS Foundation Trust· Updated 9 Jun 2026

  “Abandoned as the team couldn't get the design right for the product to work to be able to use it for the study.”Registry text, quoted unchanged. Source

• Terminated

  A Study of Loco-Regional Liposomal Bupivacaine Injection

  NCT05992896· Mayo Clinic· Updated 29 May 2026

  “Lack of funds”Registry text, quoted unchanged. Source

• Withdrawn

  Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI)

  NCT07175129· University Hospitals Cleveland Medical Center· Updated 29 May 2026

  “Closed due to slow enrollment.”Registry text, quoted unchanged. Source

• Terminated

  Shockwave ®S4 Catheter IVL to Treat Infrapopliteal Calcified Stenoses and/or Occlusions in CLTI Patients (LEGACY)

  NCT05755412· EndoCore Lab s.r.l.· Updated 25 Mar 2026

  “Low Enrollment rate: The study targeted a highly selected and complex patient population, making the identification and enrollment of eligible patients particularly challenging for all participating centers”Registry text, quoted unchanged. Source

• Withdrawn

  Improving Exercise Rehabilitation Efficacy Outcomes Veterans Peripheral Artery Disease

  NCT05648630· VA Office of Research and Development· Updated 10 Nov 2025

  “Inadequate participant recruitment”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• A contrast medium sparing strategy using automated Carbon Dioxide Injection during PERIpheral vascular interventions for PREVENTion of Major Adverse Kidney Events (MAKE): the PeriPREVENT randomized controlled trial

  2024-512876-37-00· Universitaet Leipzig· Source

• Daily Stretching to Improve Walking in Older Patients With Peripheral Artery Disease: The STRETCH PAD Study

  NCT07919483· Penn State University· Source

• Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization

  NCT07597239· Massachusetts General Hospital· Source

• Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

  NCT07318610· Regeneron Pharmaceuticals· Source

• Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

  NCT07223593· Eli Lilly and Company· Source

• REducing Systemic Inflammation With LOw-dose Colchicine to ImproVE Cardiovascular Calcification in Chronic Kidney Disease: A Pilot Randomized Open-Label Trial

  NCT07654231· University of Texas Southwestern Medical Center· Source

• EVERO Drug-coated Balloon (DCB) Randomized Trial

  NCT07144150· Cook Research Incorporated· Source

• Periodontal Status and TMAO Levels in Peripheral Artery Disease

  NCT07449546· Ankara University· Source

• Arm-crank Exercise Training on Cardiovascular Function of Patients With Peripheral Artery Disease

  NCT03837639· Hospital Israelita Albert Einstein· Source

• The Effect of a Multimodal Preventive Intervention in Patients With Asymptomatic Peripheral Artery Disease

  NCT07897396· Värmland County Council, Sweden· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

See which targets of this disease your abstract mentions, and go to the people working on them.